• adult stem cell;
  • adipose-derived stromal cells;
  • cardiomyogenic differentiation;
  • transforming growth factor-β1;
  • osteogenic differentiation


Transplanting stem cells differentiated towards a cardiac lineage can regenerate cardiac muscle tissues to treat myocardial infarction. In this study, we tested the hypothesis that transforming growth factor-β1 (TGF-β1) induces cardiomyogenic differentiation of adipose- derived stromal cells (ADSCs) in vitro. Rat ADSCs were cultured with TGF-β1 (10 ng ml−1) for 2 weeks in vitro. ADSCs cultured without TGF-β1 served as a control. The mRNA expression of cardiac-specific gene was induced by TGF-β1, while the control culture did not show cardiac-specific gene expression. Immunocytochemical analyses showed that a small fraction of ADSCs cultured with TGF-β1 for 2 weeks stained positively for cardiac myosin heavy chain (MHC) and α-sarcomeric actin. Flow cytometric analyses showed that the proportion of cells expressing cardiac MHC increased with TGF-β1. However, no mesenchymal differentiation (e.g., osteogenic and adipogenic differentiation) was detected other than cardiomyogenic differentiation. These results showed that TGF-β1 induce ADSC cardiomyogenic differentiation in vitro, which could be useful for myocardial infarction stem cell therapy. Copyright © 2009 John Wiley & Sons, Ltd.